The FinancialContent Network     SocialPicks Community   |   MarketMinute Monitor   |   MarketMinute Market Updates   |   MarketMinute Stock News
SocialPicks
   Sign Up   |   Log In   |   What is SocialPicks?     
9 pts

Opinion on  Cytori Therapeutics Inc (CYTX)     Sector: Healthcare  >  Industry: Biotechnology & Drugs
New Emerging Stem Cell Index

Feb 02, 2009 12:13 PM GMT
Mikerun
Return Risk
+1.04% MID
Principal

New Emerging Stem Cell Index
 
Shares of Geron (GERN) and other well known stem cell and regenerative medicine stocks such as Osiris Therapeutics (OSIR) and StemCells (STEM) have been soaring since the FDA allowed human clinical testing for Geron's embryonic stem cell treatment candidate for spinal cord injuries.
 
The table at my website link below highlights 25 U.S.-listed stem cell and regenerative medicine companies with market caps of below $200M which are included in the ETF Innovators Emerging Stem Cell Index. The companies are also listed below in descending order by market cap.
 
 
BioMimetic Therapeutics (BMTI)
Cytori Therapeutics (CYTX)   
RTI Biologics (RTIX)  
Aastrom Biosciences (ASTM)
Mesoblast (MBLTY)   
Neuralstem (CUR)
Osteotech (OSTE)      
ThermoGenesis (KOOL)         
RegeneRx Biopharma (RGN)  
Advanced Cell Tecchology (ACTC)    
Pluristem Therapeutics (PSTI)  
Athersys (ATHX)        
International Stem Cell Corp (ISCO)   
Stem Cell Innovations   (SCLL)
Bioheart (BHRT)
CellCyte Genetics Corp (CCYG)        
Stem Cell Therapeutics (SCTPF)         
Brainstorm Cell Therapeutics (BCLI)   
Opexa Therapeutics (OPXA)  
Stem Cell Authority (SCAL)
Neostem (NBS)          
Stem Cell Therapy Internt'l (SCII)        
Cord Blood America (CBAI)  
MultiCell Technologies (MCET)          
LifeStem International (LSTM)
 
While regenerative medicine holds enormous potential for breakthrough medical treatments, investors and traders should be cautious as the entire space is an extreme momentum trade since the FDA news to allow human testing of embryonic stem cells. President Obama is also expected to lift the federal ban under the previous administration to allow federal funding of stem cell research, providing another boon to these companies.
 
Click here for my previous articles on stem cell investing , including my favorite two companies from this index – Cytori Therapeutics and ThermoGenesis, which are developing therapeutic and stem cell banking applications derived from a patient's own fat tissue and blood or bone marrow, respectively. Both of these companies already have products on the market, in addition to ongoing clinical studies for therapeutic applications of their stem cell and regenerative medicine systems and technology platforms.


CYTX:  This call was made on 02/02/09 @ $5.0
Rating:   Positive   $5.0 (02/02/09)
Closed:   02/04/2009 @ $4.24 (-15.20% in 2 days)


Comments (3)

Add Comment

Arrow_up
Arrow_down
economics999   N/A     1 point   commented 1204 days ago reply

The Best Small Float / Small Market Cap Plays are:

PSTI Has about 8 Million Shares Outstanding 6 Million Float

ATHX Has about 18 Million Outstanding 11 Million Float

MCET Has about 76 Million Outstanding 68 Million Float

CBAI Has about 301 Million Out and 298 Million Float

LSTM Trades at around .015 and only has 64 Million Outstanding Shares
Arrow_up
Arrow_down
economics999   N/A     1 point   commented 1204 days ago reply

For More information on PSTI , ATHX , MCET.ob , CBAI.ob , or LSTM.ob ; Including Charts , Insider Ownership and Historical Prices, please use the link below.

http://finance.yahoo.com/q/cq?d=v1&s=psti,athx,%20lstm.ob,mcet.ob,cbai.ob,
Arrow_up
Arrow_down
ozipek   N/A     1 point   commented 414 days ago reply

biber hapı | Maurers | zayıflama | Lw6090 | altın çilek | Ozon Yağı | Red Pepper | fx15 | radian | Tengda Zayıflama Hapı | Tengda Kullanımı | Tengda Kullanıcı Yorumları | Tengda Sipariş | Tengda Hakkında | Tengda İçindekiler | Tengda Etkileri | Tengda Yan Etkileri | Maurers | Maurers Kullanımı | Maurers Kullanıcı Yorumları | Maurers Sipariş | Maurers Hakkında | Maurers Zayıflama Hapı | Maurers İçindekiler | Maurers Etkileri | Maurers Yan Etkileri |

Your Comment



ROCK-STAR INVESTORS
Rank Name Sharpe Ratio Avg Return Followers
1 noshoes 21.10 +34.36% 531
2 Gerald Greene 18.14 +36.28% 286
3 stockmarketfunding.com 17.66 +23.07% 83
4 akiralegrand 13.47 +13.37% 69
5 anup2104 12.13 +132.16% 102


POPULAR STOCKS
Symbol Company Name Sentiment
MOT Motorola Inc
EMC EMC Corp
WMT WalMart Stores Inc
MA MasterCard Inc
AIG American International Group Inc.
HPQ HewlettPackard Company

TODAY'S HEADLINES

TODAY'S TOP PICKS

 
Cytori Therapeutics Inc (CYTX)
   SocialPicks Sentiment:   

   This Quarter's Sentiment:
All:
83.0%
Top:
100.0%




Latest Picks by Mike Havrilla
Symbol SP Sentiment Rating Return Since
AMRN Positive +86.01% 11/29/10
IBB Positive +39.69% 11/22/10
EXAS Positive +35.19% 10/21/10
BIOD Positive -83.37% 10/17/10
LCI N/A Positive -21.73% 10/06/10

View All >
   
Mike Havrilla previously rated CYTX
Positive -54.94% Extreme FDA, Clinical Trial Trades: Stocks Under $5
04/11/2010
9
Positive +1.53% Single Digit FDA, Clinical Trial Stocks: $GNVC, $ACUR, $CADX, $CYTX
03/27/2010
9
Positive -29.17% Cytori (NASDAQ: CYTX): FDA 510(k) Celution Clearance, Heart Data Pending
01/08/2010
9
Positive +0.47% Cytori’s (NASDAQ: CYTX) Natural Celution for Breast Reconstruction
12/12/2009
9
Positive +5.05% BioMed Updates: Dec 6-8
12/08/2009
9
Positive +65.05% BioMed News Bytes: Cytori, Poniard, Alkermes, Spherix, CRXX, HGSI
11/16/2009
9
Positive -0.53% BioMed News Bytes: Cytori (NASDAQ: CYTX), Questcor (NASDAQ: QCOR)
10/16/2009
9
Positive +7.47% FDA Calendar Extreme Trades: 85 Single Digit Stocks
10/13/2009
9
Positive -4.92% BioMed News Bytes: Cytori, EXACT Sciences, HEPI
10/03/2009
9
Positive -8.04% Cytori’s Cardiac Celution: Encouraging Interim Data (NASDAQ: CYTX)
09/23/2009
9
Positive +5.29% The Latest Story on Cytori (NASDAQ:CYTX)
09/14/2009
9
Positive +51.20% Stem Cell Index Surges in Past Week
05/10/2009
9
Positive +38.12% BioMedReports.com Most Popular Links
04/09/2009
9
Positive -7.65% Cytori Therapeutics: Stock Profile and 2009 Outlook
03/14/2009
9
Positive -6.67% Stem Cell Index Soars on Lift of Funding Ban
03/10/2009
9
Positive -7.89% Analysis of Global Stem Cell Index YTD
03/04/2009
9
Positive -17.39% Cytori Therapeutics: A Natural Play on Cosmetic Medicine
03/01/2009
9
Positive -12.66% Global Stem Cell and Regenerative Medicine Index
02/25/2009
10
Positive -2.17% Global Stem Cell Index Down 9% Last Week
02/22/2009
9
Positive -21.22% Global Stem Cell and Regenerative Medicine Index
02/18/2009
9
Positive +4.06% Stem Cell Index Down 7% in Past Week
02/16/2009
9
Positive -6.86% Stem Cell Index Down 1% in Past Week
02/09/2009
9
Positive -0.24% An Expanded Emerging Stem Cell Index
02/04/2009
9
Positive +35.87% Index to Track New Era for Stem Cell Cos.
01/23/2009
9
Positive +1.94% 20 Emerging Healthcare Stocks to Watch in '09
01/10/2009
9
Positive -6.48% Stem Cell & Regenerative Medicine Stocks Surge in Past Month
12/20/2008
9
Positive +33.10% Trading the Trials: Cytori and Cypress Bio
12/09/2008
9
Positive +34.88% Eyeing Opportunities in Micro-Cap Bio-Pharma Index
12/02/2008
9
Positive -18.87% Regenerative Medicine: The Next Frontier for Big Pharma
11/17/2008
9
Positive +1.15% Cytori Therapeutics: Set for a Sale to Olympus?
11/13/2008
9
Positive -7.42% Bullish on CYTX ...
11/12/2008
0
Positive -29.25% Cosmetic & Reconstructive Medicine: An Industry Profile
10/12/2008
9
Positive -23.81% Investors Flee Stocks for Gold and Safe Havens
09/30/2008
3
Positive -25.21% Cosmetic and Reconstructive Medicine (CRM): An Industry Profile
08/15/2008
3
Positive +6.04% Cytori Therapeutics (CYTX) Relieves Funding Concern & Announces 2Q08 Operating Results
08/08/2008
3
Positive -11.02% Cytori Therapeutics Enters Agreement for StemSource Cell Bank Sales in Singapore
08/04/2008
3
Positive +30.30% The Stem Cell Celution® for Success at Cytori Therapeutics
07/15/2008
3





IN THE PRESS
Press_forbes Press_washingtonpost Press_wsj Press_npr Press_techcrunch